does bcn cover glp-1 Medicaid Drugs? A State-by-State Guide — StateVitals Paving the way for expanded

Therefore, for CY 2026, we proposed to update the CY 2025 $630 threshold amount by the four-quarter moving average PPI levels for Pharmaceuticals for Human Use, Prescription to trend the $630 threshold forward

We want to remain competitive and committed

Mounjaros prescribing information states that the drug has been associated with gastrointestinal adverse reactions, sometimes severe, and that it is not recommended in patients with severe gastroparesis

Furthermore, we proposed that the wage index that would apply for CY 2026 to non-IPPS hospitals paid ( under the OPPS would continue to include the rural floor adjustment and any policies and adjustments applied to the IPPS wage index